TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20652432

Group type: EXPERIMENTAL
Intervention: Tuna oil (210 mg EPA, 30 mg DPA, 810 mg DHA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Seal oil (340 mg EPA, 230 mg DPA, 450 mg DHA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (sunola oil)
Number of subjects: 30
Study: 22316443

Group type: EXPERIMENTAL
Intervention: Screening group (immediate measurement of thyrotropin and free T(4) levels)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (serum stored, measurements obtained shortly after delivery)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Screening group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 15986590

Group type: EXPERIMENTAL
Intervention: Vertebral fractures prevalence
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Diagnosis of osteoporosis
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Fractured vertebrae analysis
Number of subjects: 425
Study: 12521404

Group type: EXPERIMENTAL
Intervention: Smoking cessation (SC)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Wait-list control group (WLC)
Number of subjects: 66
Study: 10493085

Group type: EXPERIMENTAL
Intervention: Paroxetine 20-50 mg daily
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 92
Study: 9112194

Group type: EXPERIMENTAL
Intervention: Perfluoroperhydrophenanthrene
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Perfluoroperhydrophenanthrene in cases complicated by proliferative vitreoretinopathy
Number of subjects: 111
Study: 1767251

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin dosed twice daily
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin dosed three times daily
Number of subjects: 206
Study: 6808854

Group type: EXPERIMENTAL
Intervention: Flushing the femoral shaft cavity with carbon dioxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insertion of bone cement
Number of subjects: 0
Study: 28741050

Group type: EXPERIMENTAL
Intervention: AST-120
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AST-120 with ACE inhibitors/ARBs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo with ACE inhibitors/ARBs
Number of subjects: 0
Study: 27787876

Group type: EXPERIMENTAL
Intervention: Moderate-intensity physical activity (PA) intervention
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health education-based successful aging (SA) intervention
Number of subjects: 1635
Study: 25716539

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg single oral dosage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23261097

Group type: EXPERIMENTAL
Intervention: CO(2) insufflation during colonoscope intubation (98 patients)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Air insufflation during colonoscope intubation (97 patients)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Both groups (CO(2) and air) post-procedure
Number of subjects: 193
Study: 20171827

Group type: EXPERIMENTAL
Intervention: Palliative care intervention
Number of subjects: 400
Study: 18794642

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (Clozapine, Haloperidol)
Number of subjects: 100
Study: 15665769

Group type: EXPERIMENTAL
Intervention: Fluvastatin (Lescol) 40 mg/day or 80 mg/day
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1050
Study: 12973839

Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber, fruit and vegetable-enriched dietary intervention
Number of subjects: 399

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 399
Study: 10423657

Group type: EXPERIMENTAL
Intervention: Cetirizine (0.2 mg/kg once daily for 28 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Loratadine (0.2 mg/kg once daily for 28 days)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cetirizine and Loratadine
Number of subjects: 80
Study: 8538704

Group type: EXPERIMENTAL
Intervention: Acellular DTP vaccine (SmithKline Beecham)
Number of subjects: 14751

Group type: EXPERIMENTAL
Intervention: Acellular DTP vaccine (Chiron Biocine)
Number of subjects: 14751

Group type: EXPERIMENTAL
Intervention: Whole-cell DTP vaccine
Number of subjects: 14751

Group type: COMPARATOR
Intervention: Acellular DTP vaccines
Number of subjects: 14751

Group type: COMPARATOR
Intervention: Acellular vaccines
Number of subjects: 14751
Study: 1866164

Group type: EXPERIMENTAL
Intervention: Cytostatic treatment (Cyclophosphamide, Vincristine, Ftorafur) for 3 months for Group 1 and lifelong systemic treatment for Group 2.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (67 patients) who had not received chemotherapeutic treatment.
Number of subjects: 36
Study: 7048748

Group type: EXPERIMENTAL
Intervention: Lonazolac-Ca (200 mg three times daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Naproxen (250 mg twice daily plus 1 placebo capsule)
Number of subjects: 40
Study: 29463947

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EDA)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA)
Number of subjects: 132
Study: 27052127

Group type: EXPERIMENTAL
Intervention: Nebuliser technique assessment using nebuliser-specific checklists.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Regular evaluation by the CF-team.
Number of subjects: 32
Study: 25495887

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 22809907

Group type: EXPERIMENTAL
Intervention: Early nasojejunal nutrition
Number of subjects: 181

Group type: COMPARATOR
Intervention: Nasogastric nutrition
Number of subjects: 181
Study: 20050995

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 27
Study: 18679606

Group type: EXPERIMENTAL
Intervention: Modified Xufu Zhuyu Decoction (XFZY) plus conventional comprehensive Western medicine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional comprehensive Western medicine
Number of subjects: 60
Study: 15939844

Group type: EXPERIMENTAL
Intervention: Cognitive intervention (9-minute cognitive intervention designed to reduce novelty, increase cognitive coping, and provide a sense of control)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (standard introduction)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 28
Study: 12227873

Group type: EXPERIMENTAL
Intervention: Isotretinoin 0.1% w/w and erythromycin 4.0% w/w gel (Double Strength Isotrexin) once daily
Number of subjects: 188

Group type: COMPARATOR
Intervention: Benzoyl peroxide 5.0% w/w and erythromycin 3.0% w/w gel (Benzamycin) twice daily
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Isotretinoin/erythromycin gel
Number of subjects: 188

Group type: COMPARATOR
Intervention: Benzoyl peroxide/erythromycin gel
Number of subjects: 188
Study: 10215736

Group type: EXPERIMENTAL
Intervention: Aspirin 1 g b.d. for 14 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7533345

Group type: EXPERIMENTAL
Intervention: FK506 (tacrolimus)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CsA (cyclosporine)
Number of subjects: 50
Study: 2213396

Group type: EXPERIMENTAL
Intervention: Ibuprofen suspension at a dosage of 30 to 40 mg/kg/day
Number of subjects: 92

Group type: COMPARATOR
Intervention: Aspirin at a dosage of 60 to 80 mg/kg/day
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Ibuprofen suspension (30, 40, and 50 mg/kg/day) in a 24-week open trial
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Ibuprofen suspension
Number of subjects: 92
Study: 352972

Group type: EXPERIMENTAL
Intervention: Clonazepam with phenytoin and phenobarbital
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 24
Study: 31721131

Group type: EXPERIMENTAL
Intervention: Heart failure with better ejection fraction (HFbEF)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Extended recovery
Number of subjects: 399

Group type: COMPARATOR
Intervention: Late recovery
Number of subjects: 399

Group type: COMPARATOR
Intervention: Transient recovery
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: HFbEF
Number of subjects: 399

Group type: COMPARATOR
Intervention: Late and extended recovery
Number of subjects: 399
Study: 31888938

Group type: EXPERIMENTAL
Intervention: Short text messages three times a week for 6 months designed to improve medication adherence.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (non-health-related messages).
Number of subjects: 200
Study: 28522181

Group type: EXPERIMENTAL
Intervention: Edaravone (60 mg intravenous)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo (intravenous saline)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Edaravone
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 26400691

Group type: EXPERIMENTAL
Intervention: Philani Intervention Program (PIP) - includes Standard Care (SC) and home visits by community health workers (M=11 visits)
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Standard Care (SC) - routine antenatal care
Number of subjects: 1238
Study: 23356861

Group type: EXPERIMENTAL
Intervention: BRIGHT intervention (self-management intervention involving an information guidebook, tailored access to local resources, and telephone support)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study: 21849011

Group type: EXPERIMENTAL
Intervention: Discontinue medication (Group A)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 2-month additional medication (Group B)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 5-month additional medication (Group C)
Number of subjects: 108
Study: 19893105

Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dual associative stimulation (DAS)
Number of subjects: 12
Study: 17449984

Group type: EXPERIMENTAL
Intervention: Dry needling of the primary (key) MTrP in the infraspinatus muscle on one side
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (untreated) side
Number of subjects: 14
Study: 15475126

Group type: EXPERIMENTAL
Intervention: High contact hip stress
Number of subjects: 103

Group type: COMPARATOR
Intervention: Healthy hips
Number of subjects: 103
Study: 11482041

Group type: EXPERIMENTAL
Intervention: Triple therapy (omeprazole, amoxicillin, clarithromycin)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Omeprazole plus antibiotic placebo
Number of subjects: 85

Group type: COMPARATOR
Intervention: Ranitidine placebo (after initial treatment)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Ranitidine (after initial treatment)
Number of subjects: 85
Study: 9824409

Group type: EXPERIMENTAL
Intervention: SIT (subcutaneous immunotherapy) for birch pollen for 12, 24, or 36 months
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: SIT (subcutaneous immunotherapy) for birch pollen
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no SIT)
Number of subjects: 49
Study: 7656887

Group type: EXPERIMENTAL
Intervention: 25,000 IU vitamin A
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 2496052

Group type: EXPERIMENTAL
Intervention: abortive therapy with ergotamine tartrate plus caffeine (standard abortive therapy)
Number of subjects: 34

Group type: COMPARATOR
Intervention: standard abortive therapy accompanied by a brief educational intervention
Number of subjects: 34
Study: 970521

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 50

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 50
Study: 31613842

Group type: EXPERIMENTAL
Intervention: Higher intensity breastfeeding at 6 months
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding (dichotomous indicator)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Breastfeeding intensity at 6 months
Number of subjects: 462
Study: 30266345

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 49
Study: 27444633

Group type: EXPERIMENTAL
Intervention: Booklets for students containing information on mental health self-management and help seeking
Number of subjects: 14690

Group type: EXPERIMENTAL
Intervention: Funding for mental health support as part of a national mental health initiative
Number of subjects: 14690
Study: 26182059

Group type: EXPERIMENTAL
Intervention: Kinect-based exergame, played once or twice a week, up to a total of 24 times
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 57
Study: 23924279

Group type: EXPERIMENTAL
Intervention: AGTO intervention (manual of text and tools; face-to-face training; onsite technical assistance)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AGTO intervention (with highest number of technical assistance hours)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (routine operations)
Number of subjects: 12
Study: 21722958

Group type: EXPERIMENTAL
Intervention: Doxepin 6 mg
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Doxepin 50 mg
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 18848460

Group type: EXPERIMENTAL
Intervention: Digital group (electronic measure of pleural air leak using Millicore AB DigiVent chest drainage system)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Traditional group (standard water seal pleural chamber)
Number of subjects: 61
Study: 16734597

Group type: EXPERIMENTAL
Intervention: Pall RS1 leukocyte removal filter
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pall LipiGuard fat removal filter
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fresenius Biofil 02 leukocyte removal filter
Number of subjects: 18
Study: 12677952

Group type: EXPERIMENTAL
Intervention: Care as usual + basic education and support
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Care as usual + intensive education and support
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 1050
Study: 10348083

Group type: EXPERIMENTAL
Intervention: Objective Behavioral Index (OBI) - Dysfunctional Behaviors
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Objective Behavioral Index (OBI) - Service Utilization
Number of subjects: 136

Group type: COMPARATOR
Intervention: Service Utilization
Number of subjects: 136
Study: 8602314

Group type: EXPERIMENTAL
Intervention: Estrogen-progestin preparation
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 63
Study: 1761336

Group type: EXPERIMENTAL
Intervention: Low-dose oral aspirin
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 7067071

Group type: EXPERIMENTAL
Intervention: Intranasal flunisolide (300 micrograms/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 3882355

Group type: EXPERIMENTAL
Intervention: trimethoprim-sulfamethopyrazine (2 capsules of 250 mg trimethoprim + 200 mg sulfamethopyrazine per capsule on the 1st day and 1 capsule for the following 14 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: trimethoprim-sulfamethoxazole (2 capsules of trimethoprim 80 mg + sulfamethoxazole 400 mg per capsule twice daily for 15 days)
Number of subjects: 72
Study: 31451902

Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation (ACI) for patella defects
Number of subjects: 73

Group type: COMPARATOR
Intervention: Autologous chondrocyte implantation (ACI) for femoral condyle defects
Number of subjects: 73
Study: 30062632

Group type: EXPERIMENTAL
Intervention: Mobile app only
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Skin examination reminders
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Accountability partner
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Reminders and accountability partner
Number of subjects: 69
Study: 27359338

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (Active and Sham tDCS)
Number of subjects: 16
Study: 24926954

Group type: EXPERIMENTAL
Intervention: Intraduodenal L-tryptophan (L-Trp) at 0.075 kcal/min (total 6.75 kcal)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intraduodenal L-tryptophan (L-Trp) at 0.15 kcal/min (total 13.5 kcal)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study: 22783845

Group type: EXPERIMENTAL
Intervention: Easy-software group (low-interactive learning environment)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Complex-software group (high-interactive e-learning program)
Number of subjects: 85
Study: 20046170

Group type: EXPERIMENTAL
Intervention: Micro‐ESR
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: I/T ratio
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Platelet count
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Absolute neutrophil count (ANC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (30 neonates without signs of sepsis)
Number of subjects: 80
Study: 18419949

Group type: EXPERIMENTAL
Intervention: Urapidil (5 mg) injected into coronary artery after 10 minutes of nitroglycerin (200 microg) injection.
Number of subjects: 43

Group type: COMPARATOR
Intervention: 0.9% NaCl (5 ml) injected into coronary artery after 10 minutes of nitroglycerin (200 microg) injection (Control group).
Number of subjects: 43
Study: 16227864

Group type: EXPERIMENTAL
Intervention: Design of Experiments (DOE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple interventions assessed alone or in combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 12208225

Group type: EXPERIMENTAL
Intervention: Streptokinase treatment
Number of subjects: 144
Study: 10394020

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD), median cumulative dose 4050 mg, median duration 18 days
Number of subjects: 572

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD)
Number of subjects: 572

Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 572
Study: 7555617

Group type: EXPERIMENTAL
Intervention: 12.5 mg or 25 mg ketoprofen
Number of subjects: 345

Group type: COMPARATOR
Intervention: 200 mg ibuprofen
Number of subjects: 345

Group type: COMPARATOR
Intervention: 275 mg naproxen sodium
Number of subjects: 345
Study: 1777547

Group type: EXPERIMENTAL
Intervention: Eurobiol 25,000
Number of subjects: 6

Group type: COMPARATOR
Intervention: Eurobiol
Number of subjects: 6
Study: 7049820

Group type: EXPERIMENTAL
Intervention: 40 mg oxprenolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30904750

Group type: EXPERIMENTAL
Intervention: NetballSmart Dynamic Warm-up
Number of subjects: 81
Study: 28114922

Group type: EXPERIMENTAL
Intervention: Twice-weekly home monitoring of symptoms (CFRSD-CRISS and FEV1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 100
Study: 25669933

Group type: EXPERIMENTAL
Intervention: Everolimus combined with lower dose tacrolimus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control (combination regimen minus everolimus)
Number of subjects: 0
Study: 25029834

Group type: EXPERIMENTAL
Intervention: Electroacupuncture after arthroscopic debridement
Number of subjects: 78

Group type: COMPARATOR
Intervention: Arthroscopic debridement only
Number of subjects: 78
Study: 23786504

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 175

Group type: COMPARATOR
Intervention: Indirect assessment
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Direct measurement
Number of subjects: 175
Study: 19479852

Group type: EXPERIMENTAL
Intervention: anti-IFNalpha monoclonal antibody (mAb) therapy
Number of subjects: 0
Study: 17457444

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis (PD)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Renal transplant (TX)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 143
Study: 15141920

Group type: EXPERIMENTAL
Intervention: New test for coordinated exertion of force
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pursuit‐rotor test
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pegboard test
Number of subjects: 48
Study: 14656555

Group type: EXPERIMENTAL
Intervention: Comorbid PTSD and AD treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: PTSD alone treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: AD alone treatment group
Number of subjects: 0
Study: 10520149

Group type: EXPERIMENTAL
Intervention: Restored teeth (80 specimens) subjected to bacterial challenge for 36 days
Number of subjects: 132

Group type: COMPARATOR
Intervention: Unrestored teeth (12 specimens)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Restored teeth (40 specimens) challenged in acidified broth (pH 4.0)
Number of subjects: 132
Study: 8542488

Group type: EXPERIMENTAL
Intervention: Buffered 1% diphenhydramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plain 1% diphenhydramine
Number of subjects: 30
Study: 1668099

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.64% stannous fluoride
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sterile saline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 8
Study: 7104148

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 14
Study: 29385578

Group type: EXPERIMENTAL
Intervention: Pharmacogenomic NRT prescribing (based on OPRM1 genotype or nicotine dependence questionnaire score)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NRT patches with prescribed doses of oral NRT
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: NRT prescribing tailored to phenotype
Number of subjects: 40